Sharda Cropchem achieved its best-ever financial year in FY26, with revenue hitting ₹5,267.59 crore and net profit surging to ₹681 crore. This strong performance, driven by its asset-light model, offers shareholders a total dividend of ₹15 per share.
Sharda Cropchem Ltd FY26 Results
Sharda Cropchem Ltd recorded its strongest-ever performance in the financial year 2025-26, with consolidated revenue reaching ₹5,267.59 crore and consolidated net profit at ₹681.00 crore.
Reader Takeaway: Record profits and revenue driven by asset-light model, but pricing pressures remain a concern.
What just happened
Sharda Cropchem reported its highest-ever annual financial figures for FY 2025-26. Consolidated revenue grew to ₹5,267.59 crore, a significant increase from ₹4,319.85 crore in FY 2024-25. Consolidated net profit more than doubled, rising to ₹681.00 crore from ₹304.42 crore in the previous fiscal year.
Why this matters
This record performance highlights the company's successful execution of its asset-light business strategy amidst global economic and geopolitical challenges. The substantial profit growth and the recommended total dividend of ₹15 per share (including interim) indicate strong returns for shareholders.
The backstory
Sharda Cropchem operates an asset-light model, focusing on product registrations and intellectual property rather than manufacturing. This strategy has allowed for operational agility and strong returns. The company has been consistently expanding its global product registration portfolio.
What changes now
The company's strong financial results and a debt-free balance sheet position it favorably. The board has recommended a final dividend of ₹9 per share, making the total payout for FY26 ₹15 per share.
Risks to watch
Global oversupply in chemical markets, particularly from China, continues to exert pricing pressure, potentially impacting realization growth. Geopolitical tensions and fluctuating commodity prices also pose risks that require careful supply chain management.
Peer comparison
While specific peer performance data is not provided in the filing, Sharda Cropchem's asset-light model and registration-led growth strategy differentiate it within the broader agrochemical sector.
Context metrics (time-bound)
- Consolidated Revenue (FY26): ₹5,267.59 crore
- Consolidated Revenue (FY25): ₹4,319.85 crore
- Consolidated Net Profit (FY26): ₹681.00 crore
- Consolidated Net Profit (FY25): ₹304.42 crore
- Total Dividend (FY26): ₹15 per share
- Active Product Registrations: 3,011
- EBITDA (FY26): ₹1,181.77 crore
What to track next
Investors should monitor the company's ability to sustain its margin performance and volume growth. Tracking the progress of its pipeline of 1,004 new registration applications and market conditions in key regions like Europe will be crucial.